Daehan New Pharm Co. Ltd Cash Flow Quality Index
Daehan New Pharm Co. Ltd cash flow quality index. Daehan New Pharm Co. Ltd (054670) has a Cash Flow Quality Index of 1.70x as of September 2025. Operating cash flow of ₩4.43 Billion exceeds net income of ₩2.61 Billion, indicating high earnings quality where cash backs reported profits. See Daehan New Pharm Co. Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Daehan New Pharm Co. Ltd (2009–2024)
Cash flow quality index of Daehan New Pharm Co. Ltd from 2009 to 2024. Historical Cash Flow Quality Index for Daehan New Pharm Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Daehan New Pharm Co. Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Daehan New Pharm Co. Ltd Cash Flow Quality Index by Year (2009–2024)
Daehan New Pharm Co. Ltd cash flow quality index by year from 2009 to 2024. Year-by-year earnings quality comparison for Daehan New Pharm Co. Ltd. For the full cash flow conversion analysis, see Daehan New Pharm Co. Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.22x | ₩18.95 Billion | ₩15.47 Billion | ▲ +22.2% |
| 2023 | 1.00x | ₩12.57 Billion | ₩12.54 Billion | ▲ +70.9% |
| 2022 | 0.59x | ₩14.25 Billion | ₩24.32 Billion | ▼ -44.5% |
| 2021 | 1.06x | ₩16.58 Billion | ₩15.69 Billion | ▼ -29.7% |
| 2019 | 1.50x | ₩22.89 Billion | ₩15.24 Billion | ▼ -82.0% |
| 2018 | 8.34x | ₩20.47 Billion | ₩2.45 Billion | ▲ +343.3% |
| 2015 | 1.88x | ₩7.80 Billion | ₩4.15 Billion | ▼ -50.0% |
| 2014 | 3.76x | ₩10.02 Billion | ₩2.66 Billion | ▼ -29.1% |
| 2011 | 5.31x | ₩3.42 Billion | ₩643.55 Million | ▲ +183.2% |
| 2009 | -6.38x | ₩-2.30 Billion | ₩360.71 Million | — |